Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05422898 · ClinicalTrials.gov registry record · NA
Discussing COVID-19 Vaccines in Private Facebook Groups
A NA study of COVID-19, sponsored by George Washington University.
- Completed
- Registry status
- NA
- Development phase
- 508
- Enrollment target
- 1
- Study location
NCT05422898: Completed NA study of COVID-19, sponsored by George Washington University.
NCT05422898 is a NA study of COVID-19 that has completed, run by George Washington University. The registered enrollment target is 508 participants, below the 38,463-participant average among 298 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05422898, a NA study of COVID-19, has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- NA
- Development phase
- 508 participants
- Enrollment target
- 1
- Study location
Study Summary
As the COVID-19 pandemic persists, a sizable proportion of the U.S. population remains unvaccinated and at high risk of death and serious illness from COVID-19. Vaccine hesitancy, fueled by the proliferation of vaccine misinformation on social media, is one factor contributing to lack of vaccination. Current attempts to overcome vaccine misinformation focus on correcting or debunking falsehoods. Although debunking strategies are important components to any public health campaign, communications must also address rationales for vaccine hesitancy that vary among individuals and communities, and directly address the gist of their concerns in an empathetic, non-judgmental manner. We will conduct a randomized controlled trial to test the effectiveness of empathic, relationship-building interactions relative to standard provision of information on social media to address COVID-19 vaccine hesitancy.
Primary Outcome
Engagement includes participation in the Facebook group; satisfaction=self-rated overall satisfaction with the program (7-point scale)
Conditions Studied
Interventions
- BEHAVIORAL Gist messages on COVID-19 vaccination
- BEHAVIORAL COVID-19 vaccine information
Study Locations (1)
District of Columbia
- George Washington University - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 508 participants |
| Start Date | 2022-01-17 |
| Est. Completion | 2022-04-04 |
| Phase | NA |
What the finished NCT05422898 record still lists
NCT05422898 is an interventional study that assigns participants to a tested intervention. The registered 508 participants enrollment target is mid-sized for trials with a published cap, below the 38,463-participant average among 298 other COVID-19 trials with a reported enrollment target (99% lower).
The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 2 interventions - of which Gist messages on COVID-19 vaccination is the first listed.
NCT05422898 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT05422898 about?
NCT05422898 is a clinical study titled "Discussing COVID-19 Vaccines in Private Facebook Groups". As the COVID-19 pandemic persists, a sizable proportion of the U.S. population remains unvaccinated and at high risk of death and serious illness from COVID-19. Vaccine hesitancy, fueled by the proliferation of vaccine misinformation on social media, is one factor contributing to lack of vaccination...
What is the current status of trial NCT05422898?
This trial is currently completed. It is a NA study. The enrollment target is 508 participants. The study started on 2022-01-17. Estimated completion is 2022-04-04.
What conditions does trial NCT05422898 study?
This clinical trial studies the following conditions: COVID-19.
What interventions are being tested in trial NCT05422898?
The interventions under investigation include: Gist messages on COVID-19 vaccination (BEHAVIORAL), COVID-19 vaccine information (BEHAVIORAL).
Who is sponsoring clinical trial NCT05422898?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05422898 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05422898's enrollment target sits among peer trials
508 109th of 298 higher than 190 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Music Mindfulness Study 2a.
RECRUITING · NA
-
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
RECRUITING · NA
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Evaluating the Impact of Social Music
RECRUITING · NA
-
The SINCERE Intervention to Address COVID-19 Health Disparities
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02115295 · 508 participants · Phase 2
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
- NCT04692675 · 508 participants · NA
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
- NCT07391657 · 508 participants · Phase 3
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
- NCT07484217 · 508 participants · Phase 3
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI